Love him or hate him, Martin Shkreli, aka Pharma Bro, is calling shorts on Bitcoin ($BTC), MicroStrategy (MSTR), and a number of quantum computing stocks.
Some say Martin is desperate for attention (again) and to post contrary opinions, so people talk about him. Now that he’s a financial podcaster, the gamble could solidify his ability to read the markets or leave him scrambling to explain a high-profile flop.
Bitcoin fell 5.4% over the past day after the call and MicroStrategy fell 6.63% over the same time frame.
Martin Shkreli: public enemy number one
Martin Shkreli became public enemy number one in 2015 after he increased the price of a life-saving drug by 5,000, cementing himself as Big Pharma’s smug poster boy and earning himself the nickname “Pharma Bro.”
Two years later, his rise ended in collapse: securities fraud charges landed him a four-year prison sentence. Since his release, Shkreli’s aura has not faded. Even his staunchest detractors admit that he has an uncanny knack for reading the financial pulse.
Shkreli’s latest podcast took aim at the year’s flashiest artists. Bitcoin, MicroStrategy, and quantum computing stars like IonQ (IONQ) and Quantum Computing Inc (QUBT) are all on his list. Stocks could be flying high with huge gains in 2024, but Shkreli is betting the descent is near.
And, true to form, he reserved some harsh criticism for Michael Saylor, the Bitcoin-loving face of MicroStrategy.
“Michael Saylor is crazy. His Bitcoin bet will hurt MicroStrategy in the long term,” Shkreli said during an episode of the podcast.
Shkreli doubled down on his position despite admitting that shorting MicroStrategy was a painful position due to its stock’s stellar performance this year.
Why go against the market and MicroStrategy?
Shkreli’s bearish outlook may seem out of sync with the optimism many investors have for Bitcoin and tech stocks, but he backs his position with market observations. Highlighting the unusual state of the stock market, Shkreli highlighted recent signs of a potential reversal of momentum:
- The Dow just ended its worst losing streak since 1978: nine straight days in the red.
- Meanwhile, the S&P 500’s price-to-book ratio is veering toward dot-com bubble territory, raising alarm bells.
- If that wasn’t enough, the SPY ETF has had more stocks decline than rise for 11 consecutive days, a dismal pattern last seen in 2001.
Shkreli believes these metrics suggest market complacency and overvaluation, creating opportunities for contrarian investors.
Bitcoin, which hit new highs in 2024, is now the focus of Shkreli’s short strategy. According to Shkreli, historical trends suggest an imminent retreat of the cryptocurrency. While he did not provide a precise price target, his critical stance is in line with concerns about Bitcoin’s valuation following its meteoric rise.
“Bitcoin grew too fast, too soon. A significant correction seems inevitable,” Shkreli hinted during a recent discussion.
Is Shkreli right this time?
While Shkreli’s moral compass and past actions have been widely criticized, his ability to spot changes in market dynamics is hard to ignore.
Of course, contrarian strategies are risky. Many of the assets that Shkreli recommends shorting have demonstrated strong fundamentals or growing investor interest. For example, quantum computing stocks like IonQ are gaining momentum thanks to technological advancements and partnerships. Bitcoin also continues to enjoy widespread adoption and institutional investment.
While Shkreli’s insights are worth considering, investors should proceed with caution, especially in today’s unpredictable climate.
EXPLORE: 11 best AI cryptocurrencies to invest in 2024
Join the 99Bitcoins News Discord here for the latest market updates
The post Martin Shkreli Loads MicroStrategy Shorts: Will Pharma Brother Beat Saylor? appeared first on 99Bitcoins.